ArticleScientific reports2026

Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.

Shinya Takada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.